Diagnosis of amyotrophic lateral sclerosis

Journal of the Neurological Sciences

Volumn 160, Issue SUPPL. 1, 1998, Pages

  Rowland, Lewis P ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

Amyotrophic lateral sclerosis; Cervical spondylotic myelopathy; Clinical findings; Differential diagnosis; Electrodiagnosis; Motor neuron disease; Multifocal motor neuropathy

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; CERVICAL MYELOPATHY; CERVICAL SPONDYLOSIS; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; ELECTRODIAGNOSIS; FASCICULATION; HUMAN; MOTOR NEURON DISEASE; MOTOR NEUROPATHY; PRIORITY JOURNAL; SENSORY NEUROPATHY;

AMYOTROPHIC LATERAL SCLEROSIS; ATROPHY; BETA-N-ACETYLHEXOSAMINIDASE; CENTRAL NERVOUS SYSTEM DISEASES; CERVICAL VERTEBRAE; DIAGNOSIS, DIFFERENTIAL; ELECTROMYOGRAPHY; FASCICULATION; HUMANS; INFECTION; LYMPHOPROLIFERATIVE DISORDERS; MOTOR NEURON DISEASE; MYOSITIS, INCLUSION BODY; NEUROMUSCULAR DISEASES; PARANEOPLASTIC SYNDROMES; PERIPHERAL NERVOUS SYSTEM DISEASES; SPINAL OSTEOPHYTOSIS; THYROTOXICOSIS;

EID: 0031724091     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00193-2     Document Type: Conference Paper

References (212)

1. Belsh JM, Schiffman PL. The ALS patient perspective on misdiagnosis and its repercussions. J Neurol Sci 1996;139(Suppl):110-6.
2. Belsh JM, Schiffman PL. Misdiagnosis in patients with ALS. Arch Int Med 1990;150:2301-5.
3. Davenport RJ, Swingler RJ, Chancellor AM, Warlow CP. Avoiding false positive diagnoses of motor neurone disease: lessons from the Scottish motor neurone disease registry. J Neurol Neurosurg Psychiatry 1996;60:147-51.
4. Li TM, Swash M, Alberman E, Day SJ. Diagnosis of motor neuron disease by neurologists. J Neurol Neurosurg Psychiatry 1991;54:980-3.
5. Li TM, Alberman E, Swash M. Clinical features and associations of 560 cases of motor neuron disease. J Neurol Neurosurg Psychiatry 1990;53:1043-5.
6. Li TM, Day SJ, Aberman E, Swash M. Differential diagnosis of motorneurone disease from other neurological conditions. Lancet 1986;ii(8509):731-3.
7. Boothby JA, De Jesus PV, Rowland LP. Reversible forms of motor neuron disease; lead 'neuritis'. Arch Neurol 1974;31:18-23.
8. Wu PBJ, Kingery WS, Date ES. An EMG case report of lead neuropathy 19 years after a shotgun injury. Muscle Nerve 1995;18:326-9.
9. Rowland LP. Natural history and clinical features of amyotrophic lateral sclerosis and related motor neuron diseases. In: Calne DN, editor. Neurodegenerative Diseases, 3rd ed. Philadelphia: W.B. Saunders Co., 1993:507-21.
10. Fonseca RG, Resemde A, Silva MD, Camarago A. Chronic motor neuron disease possibly related to intoxication with organochlorine insecticides. Acta Neurol Scand 1993;88:56-8.
11. Tucker T, Layzer RB, Miller RG, Chad D. Subacute, reversible motor neuron disease. Neurology 1991;41:1541-4.
12. Tsai CP, Ho HH, Yen DJ, Wang V, Lin KP, Liao KK, Wu ZA. Reversible motor neuron disease. Eur Neurol 1993;33:387-9.
13. Louis ED, Hanley A, Brannagan TM, Sherman WH, Murphy P, Lange DJ, Trojaborg W, Younger DS, Lovelace RE, Latov N, Rowland LP. Prevalence of lymphoproliferative diseases in a cohort of patients with motor neuron disease. Muscle Nerve 1996;19:1334-7.
14. Gordon PH, Rowland LP, Younger DS, Sherman WH, Hays AP, Louis ED, Lange DJ, Trojaborg W, Lovelace RE, Murphy PL, Latov N. Lymphoproliferative disorders and motor neuron disease. Neurology 1997;48:1671-8.
15. Ikusaka M, Iwata M, Sasaki S, Uchiyama S. Progressive dysphagia due to adult Chiari 1 malformation mimicking ALS. J Neurol Neurosurg Psychiatry 1996;60:357-8.
16. Aysun S, Cinbis M, Ozcan OE. Intramedullary astrocytoma presenting as spinal muscular atrophy. J Child Neurol 1993;8:354-6.
17. Donofrio PD. Monomelic amyotrophy. Muscle Nerve 1994;17:1129-34.
18. Gerard JM, Bouton R, Harbaut AG, Delecluse F, Raftopoulos C. Le syndrome paretique du canal lombaire etroit. Rev Neurol (Paris) 1994;3:247-50.
19. Jamieson PW, Katirji MB. Idiopathic generalized myokymia. Muscle Nerve 1994;17:42-51.
20. Kennedy PGE, Duchen LW. A quantitative study of intermediolateral column cells in motor neuron disease and the Shy-Drager syndrome. J Neurol Neurosurg Psychiatry 1985;48:1103-6.
21. Noda K, Katayama S, Watanabe C, Yamamura Y, Nakamura S, Yonehara S, Inai K. Pure autonomie failure with motor neuron disease; report of a clinical study and postmortem examination of a patient. J Neurol Neurosurg Psychiatry 1996;60:351-2.
22. Bergmann M, Kuchelmeister K, Migheli A, Schiffer D, Gullotta F. Motor neuron disease with pallido-luysio-nigral atrophy. Acta Neuropathol 1993;86:105-8.
23. Utti RJ, Berry K, Yasuhara O, Eisen A, Feldman, McGeer PL, Calne DB. Neurodegenerative overlap syndrome; clinical and pathological features of Parkinson's disease, motor neuron disease, and Alzheimer's disease. Parkinsonism Rel Dis 1995;1:21-34.
24. Williams TL, Shaw PJ, Lowe J, Bates D, Ince PG. Parkinsonism in motor neuron disease; case report and literature review. Acta Neuropathol 1995;89:275-83.
25. Rowland LP. Ten central themes in a decade of ALS research. In: Rowland LP, editor. Amyotrophic Lateral Sclerosis and other Motor Neuron Diseases. New York: Raven Press, 1991:3-23 (Advances in Neurology, vol. 56).
26. Snowden JS, Neary D, Mann DMA. Pronto-temporal Lobar Degeneration; Fronto-temporal Dementia, Progressive Aphasia, Semantic Dementia. New York: Churchill Livingstone, 1996.
27. Belsh JM, Schiffman PL, editors. Amyotrophic Lateral Sclerosis. Armonk, NY: Futura Publishing Co., 1996.
28. World Federation of Neurology El Escorial Criteria for Diagnosis ALS. J Neurol Sci 1994;124(Suppl):96-107.
29. Schiffman NI, Schiffman MG. The legacy of Lou Gehrig's disease: notable people with ALS. In: Belsh JM, Schiffman PL, editors. Amyotrophic Lateral Sclerosis; Diagnosis Management for the Clinician. New York: Futura, 1996:219-58.
30. Rowland LP. Peripheral neuropathy, motor neuron disease, or neuronopathy? In: Battistin L., Hashim G.A., Lajtha A., eds. Clinical and Biological Aspects of Peripheral Nerve Diseases. New York: Alan R. Liss, 1983:27-41.
31. Rowland LP, Defendini R, Sherman W, Hirano A, Olarte MR, Latov N, Lovelace RE, Inoue K, Osserman EF. Macroglobulinemia with peripheral neuropathy simulating motor neuron disease. Ann Neurol 1982;11:532-6.
32. Ghatak NR, Campbell WW, Lippman RH, Hadfield MG. Anterior horn changes of motor neuron disease associated with demyelinating radiculopathy. J Neuropathol Exp Neurol 1986;445:385-95.
33. Lewis RA, Sumner AJ, Brown MJ, et al. Multifocal demyelinating neuropathy with persistent conduction conduction block. Neurology 1982;32:958-64.
34. Parry GJ, Clarke S. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve 1988;11:103-7.
35. Parry GJ, Holtz S, Hen-Zeev D, Drori JB. Gammopathy with proximal motor axonopathy simulating motor neuron disease. Neurology 1986;36:273-6.
36. Roth G, Magistris MR. Neuropathies with conduction block, single and grouped fasciculations, localized limb myokymia. EEG Clin Neurophysiol 1987;67:428-38.
37. Chad DA, Hammer K, Sargent J. Slow resolution of multifocal weakness and fasciculation: a reversible motor neuron syndrome. Neurology 1986;36:1260-3.
38. Pestronk A, Cornblath DR, Ilyas AA, Baba H, Quarles RH, Griffin JW, Alderson K, Adams RN. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988;24:73-8.
39. Santoro M, Thomas FP, Fink ME, Lange DJ, Uncini A, Wadia NH, Latov N, Hays AP. IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal conduction block. Ann Neurol 1990;28:373-7.
40. Roberts M, Willison HJ, Paterson G, O'Hanlon G, Vincent A, Newsom-Davis J. Human monoclonal anti-GM1 ganglioside antibodies derived from multifocal motor neuropathy patients block distal motor nerve conduction. Ann Neurol 1995;38:111-8.
41. Pakiam A, Parry G. Multifocal motor neuropathy without evidence of conduction block. Neurology 1996;46:A234.
42. Wolfe GI, Katz JS, Bryan WW, et al. Is conduction block a necessary finding in patients with multifocal motor neuropathy? Neurology 1996;46:A234.
43. Katz JS, Wolfe GI, Bryan WW, Jackson CE, Amato AA, Brohn RJ. Electrophysiologic findings in multifocal motor neuropathy. Neurology 1997;47:700-7.
44. Corbo M, Abouzahr MK, Latov N, Innaccone S, Quattrini A, Nenni R, Canal N, Hays AP. Motor nerve biopsy studies in motor neuropathy and motor neruon disease. Muscle Nerve 1997;20:15-21.
45. Adams D, Kuntzer T, Steck AJ, Lobrinus A, Janzer RC, Regli F. Motor conduction block and high titres of anti-GM1 ganglioside antibodies; pathological evidence of a motor neuropathy in a patient with lower motor neuron syndrome. J Neurol Neurosurg Psychiatry 1993;56:982-7.
46. Oh SJ, Claussen GC, Odabasi Z, Palmer CP. Multifocal demyelinating motor neuropathy: pathologic evidence of 'inflammatory demyelinating polyradiculoneuropathy'. Neurology 1995;45:1828-32.
47. Veugelers B, Theys P, Lammends M, Van Hees J, Robberecht W. Pathological findings in a patient with amyotrophic lateral sclerosis and multifocal motor neuropathy with conduction block. J Neurol Sci 1996;136:64-70.
48. Kinoshita A, Kaji R, Kawasaki T, Oka N, Kanda M, Akiguchi I. Amyotrophic with probable conduction block in the brachial plexus and giant myelinated fibers in spinal roots (submitted).
49. Rowland LP. Amyotrophic lateral sclerosis with paraproteins and autoantibodies. In: Serratrice G, Munsat T, editors. Pathogenesis and Therapy of Amyotrophic Lateral Sclerosis, vol. 68. Philadelphia: Lippincott-Raven Publishers, 1995:93-105 (Advances in Neurology).
50. Brain WR, Northfield DWC, Wilkinson M. The neurological manifestations of cervical spondylosis. Brain 1952;75:187-225.
51. Wilkinson M, editor. Cervical Spondylosis. Its Early Diagnosis and Management, 2nd ed. Philadelphia: Saunders, 1967:1971.
52. Phillips DG. Upper limb involvement in cervical spondylosis. J Neurol Neurosurg Psychiatry 1975;38:386-90.
53. De Noordhout AM, Born JD, Schoenen J, Delwaide PJ. Fasciculations in cervical spondylosis. Neurology 1996;46:A206.
54. King RB, Stoops WL. Cervical myelopathy with fasciculations in the lower extremities. J Neurosurg 1963;20:948-52.
55. Kasdon DL. Cervical spondylotic myelopathy with reversible fasiculations in the lower extremities. Arch Neurol 1977;34:774-6.
56. Romano JG, Bradley WG, Green B. High cervical myelopathy with the numb clumsy hand syndrome. J Neurol Sci 1996;140:137-40.
57. Symonds CP, Meadows SP. Compression of the spinal cord in the neighborhood of the foramen magnum. Brain 1937;60:5-84.
58. Alani SM. Denervation in wasted hand muscles in a case of primary cerebellar ectopia without syringomyelia. J Neurol Neurosurg Psychiatry 1985;45:84-5.
59. Goodridge AE, Feasby TE, Ebers WF, Brown WF, Rice GPA. Hand wasting due to mid-cervical spinal cord compression. Can J Neurol Sci 1987;14:309-11.
60. El-Mallakh RS, Rao K, Barwick M. Cervical myelopathy secondary to movement disorders: case report. Neurosurgery 1989;24:902-5.
61. Ebara S, Yonenobu K, Fujiwara K, Yamashita K, Ono K. Myelopathy characterized by muscle wasting. A different type of myelopathy hand in patients with cervical spondylosis. Spine 1988;13:785-91.
62. Swash M. Discussion, International Symposium on ALS, Glasgow, Scotland, 1997.
63. Stark RJ, Kennard C, Swash M. Hand wasting in spondyltoic high cord compression; an EMG study. Ann Neurol 1981;9:58-62.
64. Utley D, Munto P. Neurosurgery for cervical spondylosis. Br J Hosp Med 1989;13:864-9.
65. Rowland LP. Surgical treatment of cervical spondylotic myelopathy; time for a controlled trial. Neurology 1992;42:5-13.
66. Braakman R. Management of cervical spondylotic myelopathy and radiculopathy. J Neurol Neurosurg Psychiatry 1994;57:237-63.
67. Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology (Minneapolis) 1968;18:671-80.
68. Warner CL, Servidei S, Lange DJ, Miller E, Lovelace RE, Rowland LP. X-linked spinal muscular atrophy (Kennedy's syndrome). A kindred with hypobetalipoproteinemia. Arch Neurol 1990;47:1117-20.
69. Harding AE, Thomas PK, Braister M, Bradbury PG, Morgan-Hughes JA, Ponsford JR. X-linked recessive bulbospinal neuronopathy; a report of 10 cases. J Neurol Neurosurg Psychiatry 1982;45:1012-9.
70. Ferrante MA, Wilbourn AJ. The characteristic electrodiagnostic features of Kennedy's disease. Muscle Nerve 1997;20:323-9.
71. Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, Takahashi A. X-linked recessive bulbospinal neuronopathy. Brain 1989;112:209-32.
72. Olney RK, Aminoff MJ, So YT. Clinical and electrodiagnostic features of an X-linked recessive bulbospinal neuronopathy. Neurology 1991;41:823-8.
73. Ferlini A, Patrosso MC, Guidetti D, et al. Androgen receptor gene (CAG)n repeat analysis in the differential diagnosis between Kennedy disease and other motoneuron disorders. Am J Med Genet 1995;55:105-11.
74. Garofalo O, Figlewicz DA, Leigh PN, Powell JF, Meininger V, Dib M, Rouleau GA. Androgen receptor gene polymorphism in ALS. Neuromusc Disord 1993;3:195-9.
75. Parboosingh JS, Figlewicz DA, Krizus A, Meininger V, Azad NA, Newman DS, Rouleau GA. Spinobulbar muscular atrophy can mimic ALS; the importance of genetic testing in male patients with atypical ALS. Neurology 1997;49:568-72.
76. Kaneko K, Igarashi S, Miyatake T, Tsuji S. Essential tremor and CAG repeats in the androgen receptor gene. Neurology 1993;43:1618-9.
77. Johnson WG. The clinical spectrum of hexosaminidase deficiency diseases. Neurology 1981;31:1453-6.
78. Johnson WG, Wigger HJ, Karp HR, Glaubiger LM, Rowland LP. Juvenile spinal muscular atrophy; a new hexosaminidase phenotype. Ann Neurol 1982;11:11-6.
79. Navon R, Melki, Kousrahi R, Fontaine B, Turpin JC, Bathen N, Fardeau M, Rondot P, Baumann N. Juvenile onset spinal muscular atrophy phenotype caused by compound heterozygously mutations for hexosaminidase A gene. Ann Neurol 1997:in press.
80. Rondot R, Navon R, Eymard B, Fardeau M, Turpin JC, Lefere M, Bathien N, Wu Y, Baumann N. Gangliosidose à GM2 juvénile débutant par une amyotrophie spinale progressive. Rev Neurol (Paris) 1997;153:120-3.
81. Tahmoush AJ, Alfonso RJ, Tahmoush GP, Heiman-Patterson TD. Cramp-fasciculation syndrome; a treatable hyperexcitable peripheral nerve disorder. Neurology 1991;41:1021-4.
82. Denny-Brown D, Foley JM. Myokymia and benign fasciculation of muscle. Trans Assoc Am Phys 1948;61:88-96.
83. Rowland LP. Cramps, spasms, and muscle stiffness. Rev Neurol (Paris) 1985;2:261-73.
84. Eisen A, Stewart H. Not-so-benign fasciculation. Ann Neurol 1994;35:375.
85. Reed DM, Kurland LT. Muscle fasciculations in a healthy population. Arch Neurol 1963;9:363-7.
86. Fleet WS, Watson RT. From benign fasciculation and cramps to motor neuron disease. Neurology 1986;36:997-8.
87. Blexrud MD, Windebank AJ, Daube JR. Long-term follow-up of 121 patients with benign fasciculation. Ann Neurol 1993;334:622-5.
88. Fetell MR, Smallberg G, Lewis LD, et al. A benign motor neuron disorder; delayed cramps and fasciculation after poliomyelitis or myelitis. Ann Neurol 1982;11:532-6.
89. Layzer RB. The origin of fasciculations and cramps. Muscle Nerve 1994;17:1243-9.
90. Créange A, Renard JL, Millet P, Boisnic S, Felten D, Béquet D, Hauw JJ. A patient with one limb interstitial myositis with localised lipoatrophy presenting with severe cramps and fasciculations. J Neurol Neurosurg Psychiatry 1994;57:1541-3.
91. Siddique T, Nijhawan D, Hentati A. Molecular genetic basis of familial ALS. Neurology 1996;47:S37-4.
92. De Belleroche J, Orrell RW, Vrigo L. Amyototrophic lateral sclerosis; recent advance in understanding disease mechanisms. J Neuropathol Exp Neurol 1996;55:747-57.
93. Jackson M, Al-Chalabi A, Enayar ZE, Chioza B, Leigh PN, Morrison KE. Copper/zinc superoxide dismutase and sporadic amyotrophic lateral sclerosis; analysis of 155 cases and identification of a novel insertion mutation. Ann Neurol 1997;42:803-7.
94. Radumovic A, Leigh PN. Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis; correlation between genotype and clinical features. J Neurol Neurosurg Psychiatry 1996;61:565-72.
95. Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown Jr. RH. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 1997;42:646-54.
96. Bredesen DE, Ellerby LM, Hart PJ, Wiedau-Pazos M, Velentine JS. Do postranslational modifications of CuZnSOD lead to sporadic amyotrophic lateral slcerosis. Ann Neurol 1997;42:135-7.
97. Shaw CE, Enayat ZE, Powell JF, Anderso VER, Radumovic A, Al-Sarraj S, Leigh PN. Familial amyotrophic lateral sclerosis. Molecular pathology of a patient with a SOD-1 mutation. Neurology 1997;49:1612-6.
98. Rothstein JD. Therapeutic horizons for amyotrophic lateral sclerosis. Curr Opin Neurobiol 1996;6:679-87.
99. Hanash A, Leguren E, Birouk N, Clermont O, Pouget J, Bouche P, Munnich A, Brice A, Melki J. SMN gene analysis of the spinal form of Charcot-Marie-Tooth disease. J Med Genet 1997;34:507-8.
100. Christodoulou K, Kyriakides T, Hristova AH, Georgiou DM, Kalaydijieva L, Yshpekova B, Ivanova T, Weber JL, Middleton LT. Mapping of a distal form of spinal muscular atrophy with upper limb predominance to chromosome 7p. Hum Mol Genet 1995;4:1629-35.
101. Orrell RW, Habgood JJ, De Bellaroche J, Lane RJM. The relationship of spinal muscular atrophy to motor neuron disease; investigation of SMN and NAIP gene deletions in sporadic and familial ALS. J Neurol Sci 1997;145:55-61.
102. Brownell B, Oppenheimer DR, Hughes JT. Central nervous system in motor neuron disease. J Neurol Neurosurg Psychiatry 1970;33:338-57.
103. Heene R, Kolander D, Knisatschek H. Die chronisch-progrediente spinobulbare Spastik (primare Lateralsklerose). Ftschrt Neurol Psychiat 1996;64:192-203.
104. Konagaya M, Sakai M, Iida M, Hashizume Y. An autopsied case of dominantly affecting upper motor neuron with atrophy of the frontal and temporal lobes - with special reference to primary lateral sclerosis (Japanese). Rinsho Sinkieigaku (English language abstract, Medline UI 95339641) 1995;35:384-90.
105. Lawyer T, Netsky MG. ALS. Clinico-anatomic study of 53 cases. Arch Neurol Psychiatry 1953;69:171-92.
106. Hudson AJ, Kiernan JA, Munoz DG, Pringle CE, Brown WF, Ebers GC. Clinicopathological features of primary lateral sclerosis are different from amyotrophic lateral sclerosis. Brain Res Bull 1993;30:359-64.
107. Norris Jr. FH, Shepherd R, Denys E, et al. Onset, natural history, and outcome in idiopathic adult motor neuron disease. J Neurol Sci 1993;118:48-55.
108. Younger DS, Chou S, Hays AP, et al. Primary lateral sclerosis. A clinical diagnosis reemerges. Neurology 1988;38:1304-7.
109. Jeffery DR. Chronic progressive myelopathy; diagnostic analysis of cases with and without sensory involvement. J Neurol Sci 1996;142:153-6.
110. Bruyn RP, Koehman JH, Troost D, de Jong JM. Motor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis. J Neurol Neurosurg Psychiatry 1995;58:742-4.
111. Pringle CE, Hudson AJ, Munoz DG, Kierman JA, Brown WF, Evers GC. Primary lateral sclerosis; clinical features, neuropathology, and diagnostic criteria. Brain 1992;115:495-520.
112. Caselli RJ, Smith BE, Osborne D. Primary lateral sclerosis; a neuropsychological study. Neurology 1995;45:2005-9.
113. Tatum WO, Coker SB, Ghobrial M, Abdu-Allah S. The open opercular sign; diagnosis and significance. Ann Neurol 1989;25:196-9.
114. Weller M, Poremba M, Dichgans J. Opercular syndrome without opercular lesions; Foix-Chavany-Marie syndrome in progressive supranuclear motor system degeneration. Eur Arch Psychiatry Clin Neurosci 1990;239:370-2.
115. Weller M. Anterior opercular cortex lesions cause dissociated lower cranial nerve palsies and anarthria but no aphasia; Foix-Chavany-Marie syndrome and automatic voluntary dissociation revisited. J Neurol 1993;240:190-208.
116. Brouselle E, Bakchine S, Tommasi M, et al. Slowly progressive dysarthria with late opercular syndrome; a variant of frontal cortical atrophy syndromes. J Neurol Sci 1996;144:44-58.
117. Delisle MB, Gorce P, Hirsch E, Hauw JJ, Rascol A, Bouissou H. Motor neuron disease, parkinsonism, and dementia. Report of a case with diffuse Lewy-body-like intracytoplasmic inclusions. Acta Neuropathol (Berlin) 1987;75:104-8.
118. Ladurner G, Budka H. Diffuse Lewy body disease as substrate of primary lateral sclerosis. J Neurol 1995;242:59-63.
119. Kitamoto T, Amano N, Terao Y, et al. A new inherited prion disease (P105L mutation) showing spastic paraparesis. Ann Neurol 1993;34:808-13.
120. Kaneko A, Narabayashi Y, Itokawa K, et al. A case of Machado-Joseph disease presenting with spastic paraparesis. J Neurol Neurosurg Psychiatry 1997;62:542-3.
121. Lerman-Sagie T, Filiano J, Smith DW, Korson M. Infantile onset of hereditary ascending paralysis with bulbar involvement. J Child Neurol 1996;11:54-7.
122. Toma S, Shiozawa Z. Amyotrophic cervical myelopathy in adolescence. J Neurol Neurosurg Psychiatry 1995;58:56-64.
123. Takemitsu M, Murayama K, Saga T, Michihiro N, Shihara H, Kimisuka M, Nonaka I. Monomelic muscle atrophy. Neuromusc Disord 1993;3:311-7.
124. Di Muzio A, Pizzi CD, Lugaresi A, Ragno M, Uncini A. Benign monomelic amyotrophy of lower limb; a rare entity with a characteristic muscular CT. J Neurol Sci 1994;126:153-61.
125. Munsat TL, editor. The Post-polio Syndrome. Boston: Butterworth, 1991.
126. Borg K. Post-polio muscle dysfunction (29th ENMC Workshop). Neuromusc Disord 1996;6:75-80.
127. McComas AJ, Quartly C, Griggs RC. Early and late losses of motor units after poliolmyelitis. Brain 1997;120:1415-21.
128. Mulder DW. The postpolio syndrome. Handbook Clin Neurol 1991;59:35-40.
129. Hoffman PM, Festoff BW, Giron Jr. LT, et al. Isolation of LAV/ HTLV-3 from a patient with amyotrophic lateral sclerosis. New Engl J Med 1985;313:324-5.
130. Verma RK, Ziegler DK, Kepes JJ. HIV-related neuromuscular syndrome simulating motor neuron disease. Neurology 1990;40:544-6.
131. Sher J, Wrzolek M, Shmuter Z. Motor neuron disease associated with AIDS. J Neuropathol Exp Neurol (Abstract) 1988;47:303.
132. Goldstein JM, Azizi SA, Brown J, et al. Human immunodeficiency virus-associated motor axonal polyradiculoneuropathy. Arch Neurol 1993;50:1316-9.
133. Huang PP, Chin R, Song S, Lasoff S. Lower motor neuron dysfunction associated with human immunodeficiency virus infection. Arch Neurol 1993;50:1328-30.
134. Mitsumoto H, Chad DA, Pioro EP. Amyotrophic Lateral Sclerosis. Philadelphia: FA Davis, 1997:242-43.
135. Kuroda Y, Sugihara H. Autopsy report of HTLV1-associated myelopathy presenting with ALS-like manifestations. J Neurol Sci 1991;106:199-205.
136. Alaoui-Faris ME, Medejel A, Al Zemmouri K, Yahyaoui M, Chkili T. Le syndrome de sclérosis laterale amyotrophique d'origine syphilitique. Rev Neurol (Paris) 1990;146:41-4.
137. Stefanis L, Rowland LP, Houston H. Merritt and neurosyphilis, then and now. P&S Med Rev 1995;2:28-35.
138. Halperin JJ, Kaplan GP, Brazinsky S, et al. Immunologic reactivity against Borrelia burgdorfi in patients with motor neuron disease. Arch Neurol 1990;47:586-94.
139. Hemmer B, Glocker FX, Kaiser R, Lucking CH, Deuschl G. Generalised motor neuron disease as an unusual manifestation of Borrelia burgdorferi infection. J Neurol Neurosurg Psychiatry 1997;63:257-8.
140. Deibener J, Kaminsky P, Debourverie M, et al. Syndrome du motorneurone et maladie de Lyme. Lien de causalite ou association fortuite? Presse Med 1997;26:1144.
141. Hausel Y, Ackerl M, Stanek G. ALS-ahnlicher Krankheitsverlauf bei chronischer Neuroborreliose. Wien Med Wchnschr 1995;145:186-8.
142. Salazar AM, Masters CL, Gajdusek DC, Gibbs Jr. CJ. Syndromes of amyotrophic lateral sclerosis and dementia; relation to transmissible Creutzfeldt-Jakob disease. Ann Neurol 1983;14:17-26.
143. Connolly JH, Allen IV, Dermott E. Transmissible agent in the amyotrophic form of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1988;51:1459-60.
144. Worrall B, Rowland LP, Del Bene M, Leung D, Chin SS. Mother with amyotrophic lateral sclerosis and daughter with Creutzfeldt-Jakob disease: coincidence or clue to pathogenesis? (submitted).
145. Collard M, Bakchine S, Duyckerts C. Instabilite de la march, dysphonie et dysphagie, paraparesie avec amyotrophie et deterioration intellectulle progressives chex un homme de 56 ans. Rev Neurol 1991;147(4):323-8.
146. Eisen A, Berry K, Gibson G. Inclusion body myositis (IBM): myopathy or neuropathy? Neurology 1983;33:1109-14.
147. Griggs RC, Askanas V, DiMauro S, Engel AG, Karpati G, Mendell JR, Rowland LP. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-13.
148. Lotz BP, Engel AG, Nishino H, et al. Inclusion body myositis; observations on 40 patients. Brain 1989;112:727-47.
149. Lindberg C, Oldfors A, Hestrom A. Inclusion body myositis: peripheral nerve incolvement. Combined morphological and electrophysiological sutdies on peripheral nerves. J Neurol Sci 1990;99:327-38.
150. Carpenter S. Inclusion body myositis, a review. J Neruopathol Exp Neurol 1996;55:1105-14.
151. Garlepp MJ, Mastaglia FL. Inclusion body myositis. Review. J Neurol Neurosurg Psychiatry 1996;60:251-5.
152. Amato AA, Gronseth GS, Jackson CE, Wolfe GI, Katz JS, Bryan WW, Barohn RJ. Inclusion body myositis: clinical and pathological boundaries. Ann Neurol 1996;40:581-6.
153. Luciano CA, Dalakas MC. Inclusion body myositis: no evidence for a neurogenic component. Neurology 1997;48:29-33.
154. Brannagan T, Hays AP, Lange DJ, Trojaborg W. The role of quantitative electromyography in inclusion body myositis. J Neurol Neurosurg Psychiatry (in press).
155. Denny-Brown DE. Primary sensory neuropathy with muscular changes associated with carcinoma. J Neurol Neurosurg Psychiatry 1948;11:73-87.
156. Wyburn-Mason R. Bronchial carcinoma presenting as polyneuritis. Lancet 1948;i:203-6.
157. Brain WR, Croft PB, Wilkinson M. Motor neurone disease as a manifestation of neoplasm (with a note on the course of classical motor neurone disease). Brain 1965;88:479-500.
158. Lord B, Norris FH Jr, editors. The Remote Effects of Cancer on the Nervous System. New York: Grune and Stratton, 1965.
159. Norris FH Jr, Engel WK. Carcinomatous amyotrophic lateral sclerosis. In ref 7; 24-34.
160. Adams RD. Discussion of Ref 8, p. 39.
161. Rowland LP. Discussion of Ref 8, p. 40.
162. Rosenfield D, Posner JB. Motor neuron disease and malignant tumors. In: Rowland LP, editor. Amyotrophic Lateral Sclerosis and other Motor Neuron Diseases. New York: Raven Press, 1991:445-62.
163. Gubbay SS, Kahana E, Zilber N, et al. Amyotrophic lateral sclerosis. A study of its presentation and prognosis. J Neurol 1985;232:295-300.
164. Buchanan DS, Malamud N. Motor neurone disease with renal cell carcinoma and postoperative neurological remission. Neurology 1973;28:891-4.
165. Evans BS, Pagan C, Arnold T, Dropcho EJ, Oh SJ. Paraneoplastic motor neuron disease and renal cell carcinoma; improvement after nephrectomy. Neurology 1990;40:960-3.
166. Gerling GM, Woolsey RM. Paraneoplastic motor neuron disease. Mo Med 1967;64:503-6.
167. Mitchell DM, Olczak SA. Remission of a syndrome indistinguishable from motor neuron disease after resection of bronchial carcinoma. Br Med J 1979;2:176-7.
168. Stephens TW, Rougas A, Ghose MK. Pure motor neuropathy complicating carcinoma of the bronchus recovered after surgery. Br J Dis Chest 1966;60:107-9.
169. Rowland LP, Schneck S. Neuromuscular disorders associated with malignant neoplastic disease. J Chron Dis 1963;16:777-95.
170. Schold SC, Cho ES, Sonasundaram M, Posner JP. Subacute motor neuronopathy; a remote effect of lymphoma. Ann Neurol 1979;5:271-87.
171. Forsyth PA, Dalmau J, Graus F. Cwik V. Rosenblum MK, Posner JB. Motor neuron syndromes in cancer patients. Ann Neurol 1997.
172. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuropathy. Medicine 1992;71:59-72.
173. Verma A, Berger JR, Snodgrass S, Petito C. Motor neuron disease: a paraneoplastic process associated with anti-Hu antibody and small cell lung carcinoma. Ann Neurol 1996;40:112-6.
174. Kiernan JA, Hudson AJ. Anti-neurone antibodies are not characteristic of amyotrophic lateral sclerosis. Neuroreport 1993;4:427-30.
175. Hays AP, Roxas A, Sadiq SA, Vallejos H, D'Agati V, Thomas FP, Torres R, Sherman WH, Bailey-Braxton D, Hays AG, Rowland LP, Latov N. A monoclonal IgA in a patient with amyotrophic lateral sclerosis reacts with neurofilaments and surface antigen on neuroblastoma cells. J Neuropathol Exp Neurol 1990;49:383-98.
176. Brownell B, Trevor-Hughes J. Central nervous system in motor neuron disease. J Neurol Neurosurg Psychiatry 1970;33:338-57.
177. Younger DS, Chou S, Hays AP, Lange DJ, Emerson R, Brin M, Thompson Jr. H, Rowland LP. Primary lateral sclerosis: a clinical diagnosis reemerges. Arch Neurol 1988;45:1304-7.
178. Evans BK, Pagan C, Arnold T, Dropcho EJ, Oh SJ. Paraneoplastic motor neuron diease and renal cell carcinoma; improvement after nephrectomy. Neurology 1990;40:960-2.
179. Notermans NC, Lokhorst HM, Franssen H, et al. Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammoopathy of undetermined significance. Neurology 1996;47:1227-33.
180. Gordon PH, Rowland LP, Younger DS, Sherman WH, Hays AP, Louis ED, Lange DJ, Trojaborg W, Lovelace RE, Murphy PL, Latov N. Lymphoproliferative disorders and motor neuron disease. Neurology 1997;48:1671-8.
181. Rowland LP, Gordon PH, Younger DS, Sherman WH, Hays AP, Louis ED, Lange DJ, Trojaborg W, Lovelace RE, Murphy PL, Latov N (Letter-to-the-Editor). Lymphoproliferative disorders and motor neuron disease. Neurology 1997.
182. Schold SC, Cho ES, Somasundaram M, Posner JB. Subacute motor neuronoopathy: a remote effect of lymphoma. Ann Neurol 1979;5:271-87.
183. Bulens C. Neurologic complications of hyperthyroidism. Remission of spastic paraplegia, dementia, and optic atrophy. Arch Neurol 1981;38:669-70.
184. Cashman N, Antel J, Wissman G, Bader P. Hyperthyroidism and familial ALS. Ann Neurol (Abstract) 1983;14:118.
185. Cervino JM, Mussio-Fournier JC, Muxi F, et al. Pyramidal tract symptoms in Basedow's disease. Med Klin 1959;54:1692-3.
186. Feibel JH, Campa JR. Thyrotoxic neuropathy (Basedow's paraplegia). J Neurol Neurosurg Psychiatry 1976;39:491-7.
187. Fisher M, Mateer JE, Ullrich I, Gutrecht JA. Pyramidal tract deficits and polyneuropathy in hyperthyroidism. Combination clinically mimicking ALS. Am J Med 1985;78:1041-4.
188. Garcia CA, Fleming RH. Reversible corticospinal tract disease due to hyperthyroidism. Arch Neurol 1977;34:647-8.
189. Harman JB, Richardson AT. Generalized myokymia in thyrotoxicosis. Lancet 1954;ii:473-4.
190. McMenanim J, Croxon M. Motor neurone disease and hyperthyroid Graves disease; a chance association? J Neurol Neurosurg Psychiatry 1980;43:46-9.
191. Melamed E, Berman M, Levy S. Posterolateral myelopathy associated with thyrotoxico sis (Letter). New Engl J Med 1975;295:778-9.
192. Ravera JJ, Cervina JM, Fernandez G, et al. Two cases of Graves disease with signs of a pyramidal lesion. Improvement in neurological signs during treatment with antithyroid drugs. J Clin Endocrinol Metab 1960;20:876-80.
193. Rosati G, Aiello I, Tola R, Granieri E. ALS associated with thyrotoxicosis. Arch Neurol 1980;37:530-1.
194. Malapert D, Brugieres P, Degos JD. Motor neuron syndrome in the arms after radiation treatment. J Neurol Neurosurg Psychiatry 1991;54:1123-4.
195. Bradley WG, Tobison SH, Tandan R, Besser D. Post-radiation motor neuron syndromes. Rowland LP, editor. Amyotrophic Lateral Sclerosis and other Motor Neuron Diseases. New York: Raven Press (Adv Neurol) 1991;56:341-56.
196. Rowland LP. Motor neuron diseases: the clinical syndromes. In: Mulder DW, editor. The Diagnosis and Treatment of Amyotrophic Lateral Sclerosis. Boston: Houghton Mifflin, 1980:7-27.
197. Shapiro BE, Bordorf G, Schwann L, Preston DC. Delayed radiation-induced bulbar palsy. Neurology 1996;46:1604-6.
198. Poncelet AN, Auger RG, Silber MH. Myokymic discharged of the tongue after radiation of the head and neck. Neurology 1996;46:259-60.
199. Harper CM, Thomas JE, Cascino TL, Lichty WJ. Distinction between neoplastic and radiation-induced brachial plexopathy, with emphasis on the role of EMG. Neurology 1989;39:502-6.
200. Brown J, Gregory R, Squier M, Donaghy M. The post-irradiation lower motor neuron syndrome. Neuronopathy or radiculopathy? Brain 1996;119:1429-39.
201. Lynch T, Sano M, Marder KS, et al. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyoytrophy complex. Neurology 1994;44:1878-84.
202. Sima AAF, Defendini R, Keohane C, D'Amato C, Foster NL, Parchi P, Gambetti P, Lynch T, Wilhelmsen K. The neuropathology of chromosome 17-linked dementia. Ann Neurol 1996;39:734-43.
203. Petersen RB, Tabaton M, Chen SG, Monari L, Richardson SL, Lynch T, Manetto V, Lanska DJ, Markesberry WR, Currier RD, et al. Familial progressive subcortical gliosis; presence of prions and linkage to chromosome 17. Neurology 1995;45:1062-7.
204. Wijker M, Wszolek ZK, Wolters ECH, Rooimans MA, Pals G, Pfeiffer RF, Lynch T, Rodnitzky RL, Wilhelmsen KC, Arwert F. Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21. Hum Mol Genet 1996;5:151-4.
205. Baker M, Kwok JBJ, Kucera S, et al. Localization of frontotemporal dementia with parkinsonism in an Australian kindred to chromosome 17q21-22. Ann Neurol 1997;42:794-8.
206. Brait K, Fahn S, Schwarz GA. Sporadic and familial parkinsonism and motor neuron disease. Neurology 1973;23:990-1002.
207. Majoor-Krakauer D, Ottman R, Johnson WG, Rowland LP. Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility. Neurology 1994;44:1872-7.
208. Rosenberg RN. Amyotrophy in multisystem genetic diseases. In: Rowland LP, editor. Human Motor Neuron Diseases. New York: Raven, 1982:149-58.
209. Teitelbaum JS, Zatorre RJ, Carpenter S, Gendron D, Cashman NR.
210. Shy GM, Drager GA. A neurological syndrome associated with orthostatic hypotension. Arch Neurol 1960;2:511-27.
211. Wenning GK, Tison F, Shlomo B, Daniel SE, Quinn NP. Multiple system atrophy; a review of 203 pathologically proven cases. Movement Disord 1997;12:133-47.
212. Sima AA, Caplan M, D'Amato CJ, Pevzner M, Furlong JW. Fulminant multiple system atrophy in a young adult presenting as motor neuron disease. Neurology 1993;43:2031-5.